Publications

RIPK1 inhibition reduces biliary injury and fibrosis in primary sclerosing cholangitis

Download PDF
Resource: RIPK1 inhibition reduces biliary injury and fibrosis in primary sclerosing cholangitis

.

Related Articles

Multi-omic spatial profiling reveals the unique virus-driven immune landscape of COVID-19 placentitis

Link

ADT-1004: a first-in-class, oral pan-RAS inhibitor with robust antitumor activity in preclinical models of pancreatic ductal adenocarcinoma

Link